Bioelectronics Corp (BIEL)

[GetSeriousOK]

the Patent expires March 2023.

Notice I said "patent" not "patents" because they only have one that counts: 7551957, and it expires March 6, 2023

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=7&f=G&l=50&co1=AND&d=PTXT&s1=BioElectronics.ASNM.&OS=AN/BioElectronics&RS=AN/BioElectronics

They also have patent 8412328 but it's a continuation, and continuations expire on the same date as the patent being continued.

They also have some Dxxx patents but those are Design patents -- "for Ornamental designs." Those don't protect BIEL's PEMF device.

What this means:

1. BIEL's Keystone Kops routine with the FDA has wasted so much time that there's little time left to really make a profit. Assume they get Allay, ActiPatch, or RecoveryRx on the market, spend $$$ millions on marketing and advertising, and finally generate some sales... the generics can come on the market in March 2023 and take away market share. BIEL will have done the expensive public awareness part... paving the road for the generics that drive the price down.

2. Any potential partner will be looking hard at that date of March 6th, 2023. Why split the pie with Andy and his gang when they can clone the device and sell it themselves in March 2023?

3. Since the parts are already made in China... how cheap will the ActiPatch clones be on AliBaba after March 6th 2023?

4. If Kelly wants to call the loan into default, take the patent, and sell it, she doesn't have much time. A patent that has less than five years left isn't worth as much as it was worth earlier, especially since BIEL doesn't have a successful profitable device yet. If Kelly is thinking about doing this, she can't wait much longer.

Andy and his gang are FAST running out of time. There is no chance of "oh but in 10 years the profits will be BILLIONS...." being the pioneer in this field only pays off if you actually ACCOMPLISH something to generate revenues before the patent expires, and this company is really REALLY close to missing that completely.

They've already missed out on the "Billions" part... and even if they manage to turn a profit of, oh let's say $1 million per quarter, doubtful with the upcoming marketing and advertising expenses but let's be optimistic here, let's say they generate a profit of $1 million by Q4 2019... That 20 billion O/S is looking pretty horrific when you consider that a profit of $1 million divided among 20 billion shares is only 0.00005 per share.

And their pipeline isn't really a pipeline -- it's just one piece of technology used multiple ways -- all protected by patent 7551957. When that patent expires in less than five years, they will have nothing left that's patent protected, other than their "ornamental designs." (And those aren't that good anyway -- one of them is "tape.")